ELIXIR PHARMATECH
Latest round
- Seed
Last raised
- Dec 2023
Total raised
- $1.2M
Investors
- 2
About ELIXIR PHARMATECH
, Ltd. doing business as Elixir Pharmatech operates as a manufacturing company providing medical drugs that are studied to provide solutions to gastrointestinal tract inflammations. Elixir Pharmatech manufactures immuno-inflammatory drugs through genetic manipulation and expression. The company’s medicine is developed through a variety of derivatives based on various small molecules, natural products, polysaccharides, polymers, inorganic nanoparticles, and many more. In addition, the firm provides synthetic drugs and peptide drugs for curing intestinal membrane.
Who invested in ELIXIR PHARMATECH
2 investors across 2 rounds
See all investors in ELIXIR PHARMATECH
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ELIXIR PHARMATECH
Who invested in ELIXIR PHARMATECH?
ELIXIR PHARMATECH has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ELIXIR PHARMATECH raised?
ELIXIR PHARMATECH has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ELIXIR PHARMATECH last raise money?
ELIXIR PHARMATECH's most recent round on record is a Seed, in Dec 2023.
What does ELIXIR PHARMATECH do?
ELIXIR PHARMATECH is a biotechnology company.
Where is ELIXIR PHARMATECH headquartered?
ELIXIR PHARMATECH is headquartered in Seoul, South Korea.
Which VCs invest in companies like ELIXIR PHARMATECH?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at ELIXIR PHARMATECH's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ELIXIR PHARMATECH? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.